ILCG iShares Morningstar Growth ETF

Expense Ratio
0.04%
Dividend
0.42%
Previous close
$115.59
Est. 12 months change
+18.28%
Projected Price
$136.72

Profitability Metrics

Return on Equity (ROE)
57.43%
Return on Assets (ROA)
18.70%
Return on Invested Capital (ROIC)
46.26%
Weighted Average Cost of Capital (WACC)
11.78%
ROIC - WACC
34.48%
Updated : 2026-05-25 21:12 ET

Valuation Metrics

P/E Ratio
34.87
Forward P/E
26.09
PEG Ratio
1.68
Debt Current Ratio
2.11

Growth & Cash Flow

Gross Margin
60.41%
Operating Margin
33.38%
FCF Margin
27.95%
TTM Revenue Growth
39.08%
Projected 12M EPS Growth
33.64%

Price Change

Price % from 50 SMA
9.28%
Price % from 200 SMA
11.26%
6 Months
15.50%
1 Year
28.60%
2 Years
49.55%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NVDA16.11%
AAPL6.82%
AVGO5.97%
AMZN5.43%
GOOGL4.81%
MSFT4.40%
GOOG4.14%
META4.07%
LLY2.50%
AMD2.25%

ETF Analysis

Fund Overview

iShares Morningstar Growth ETF (ILCG) currently reports 328 stock positions (subject to change), placing it in the widely diversified range by holdings breadth. The top line-up is NVDA (16.11%), AAPL (6.82%), AVGO (5.97%), with NVDA as the largest single weight at 16.11%. Together, the top three holdings account for 28.90%, which suggests a more balanced distribution of weight across the portfolio, reducing single-name sensitivity at the top. Taken together, the portfolio's structure reflects a deliberate trade-off between conviction at the top and risk spreading across the broader holding set.

Profitability & Capital Efficiency

On a capital return basis, ROIC is 46.26%, WACC is 11.78%, and the economic spread is 34.48%. On balance, the portfolio's businesses are compounding at rates that meaningfully exceed what capital costs would otherwise allow. Supporting metrics show ROE at 57.43% and ROA at 18.70%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

On an earnings multiple basis, trailing P/E of 34.87, forward P/E of 26.09, PEG of 1.68. The spread between trailing and forward P/E is moderate, suggesting some earnings improvement is expected but not a dramatic re-rating. The PEG ratio sits in a range that most investors would consider fair — neither cheap nor obviously stretched relative to anticipated earnings. A current ratio of 2.11 suggests the holdings have sufficient short-term liquidity without excess. Combining multiples and liquidity, the portfolio appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.

Margins & Cash Generation

Stripping to unit economics, gross margin sits at 60.41%, operating margin at 33.38%, and free cash flow margin at 27.95%. Gross margins are exceptional, reflecting strong pricing power and a defensible cost structure. At this operating margin level, the portfolio's holdings demonstrate strong operational discipline and meaningful earnings leverage. The portfolio's free cash flow margin is exceptional, pointing to capital-light businesses with strong reinvestment optionality. Together, these margin readings describe a portfolio of businesses that protect profitability at every layer of the income statement.

Growth & Forward Outlook

Connecting operational trends with market expectations, TTM revenue growth of 39.08% indicating strong organic momentum at the portfolio level, while the estimated 12-month price change of 18.46%, where consensus targets suggest reasonable upside rather than a step-change rerating. At 33.6%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The aggregate picture across capital efficiency, valuation, growth, and cash generation builds a compelling case.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.